R. Wells

Predictors for Improvement in Patient-Reported Outcomes: Post-Hoc Analysis of a Phase 3 Randomized, Open-Label Study of Eculizumab and Ravulizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

H. Schrezenmeier, K. Johnston, J. Lee, 2021, Blood.

PPA_A_233830 705..715

Eld, D. Cella, S. Yount, 2020 .

Pharmacogenetics of Lethal Opioid Overdose: Review of Current Evidence and Preliminary Results from a Pilot Study

D. Müller, B. Le Foll, R. Jhirad, 2023, Journal of personalized medicine.